Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy

被引：0
|
作者：
Michelle Shayne
Jeffrey Crawford
David C. Dale
Eva Culakova
Gary H. Lyman
机构：
[1] University of Rochester Medical Center,James P. Wilmot Cancer Center
[2] Duke University Medical Center,Medical Oncology and Transplantation
[3] University of Washington,Department of Medicine
来源：
Breast Cancer Research and Treatment | 2006年 / 100卷
关键词：
Early-stage breast cancer; Adjuvant chemotherapy; Dose intensity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：255 / 262
页数：7
相关论文
共 50 条
  • [1] Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy
    Shayne, Michelle
    Crawford, Jeffrey
    Dale, David C.
    Culakova, Eva
    Lyman, Gary H.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 (03) : 255 - 262
  • [2] Predictors of reduced relative dose intensity (RDI) in patients with early-stage breast cancer (ESBC) receiving adjuvant chemotherapy (CT).
    Lyman, GH
    Crawford, J
    Dale, DC
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S49 - S49
  • [3] Factors associated with reduced dose intensity in patients receiving adjuvant chemotherapy for early-stage breast cancer (ESBC).
    Lyman, GH
    Wolff, DA
    Culakova, E
    Poniewierski, A
    Dale, DC
    Crawford, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S60 - S60
  • [4] A prospective assessment of variables contributing to reduced relative dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy.
    Shayne, M
    Culakova, E
    Wolff, D
    Poniewierski, M
    Lyman, GH
    Dale, DC
    Crawford, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S110 - S110
  • [5] Baseline MUGA scans for patients with early-stage breast cancer receiving adjuvant chemotherapy
    Jeyakumar, A. S.
    Dipenta, J.
    Snow, S. L.
    Rayson, D.
    Thompson, K.
    Theriault, C.
    Younis, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Adjuvant chemotherapy for early-stage breast cancer
    McArthur, Heather L.
    Hudis, Clifford A.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (02) : 207 - +
  • [7] Racial disparity in dose intensity of early-stage breast cancer chemotherapy
    Rosenzweig, Margaret Q.
    Mazanec, Susan R.
    Brufsky, Adam
    Gordon, Brittaney-Belle Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] Optimal Adjuvant Chemotherapy Regimens for Patients With Early-Stage Breast Cancer
    Del Mastro, Lucia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (10) : 1137 - +
  • [9] Optimizing adjuvant chemotherapy in early-stage breast cancer
    Perez, Edith
    Muss, Hyman B.
    [J]. ONCOLOGY-NEW YORK, 2005, 19 (14): : 1759 - 1767
  • [10] Dose delays, dose reductions, and relative dose intensity in early stage breast cancer patients receiving (neo) adjuvant chemotherapy in community oncology practices
    Favret, A. M.
    Li, X.
    Denduluri, N.
    Morrow, P. K.
    Bhor, M.
    Barron, R. L.
    Dhanda, R.
    Langeberg, W. J.
    Saravanan, S.
    Girardi, V.
    Lyman, G. H.
    [J]. CANCER RESEARCH, 2013, 73
12345